BFLY
Butterfly Network, Inc.
BFLY offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
OSCR
Oscar Health, Inc.
OSCR has the edge over BFLY overall, supported by stronger fundamentals and lower modeled downside.
BFLY Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
BFLY's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
BFLY PE Valuation
BFLY has no meaningful PE right now: it lost money over the past year.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
BFLY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect BFLY's losses to shrink, with revenue growing.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
BFLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.21 | +$0.13 |
| Q2 2026 | -$0.29 | $0.00 |
| Q1 2026 | -$0.30 | $0.00 |
| Q4 2025 | -$0.31 | +$0.03 |
| Q3 2025 | -$0.34 | +$0.12 |
| Q2 2025 | -$0.29 | +$0.22 |
| Q1 2025 | -$0.30 | +$0.28 |
| Q4 2024 | -$0.34 | +$0.31 |
BFLY is still losing money, but far less than before: $0.21 per share over the past year, against $0.84 at its worst in late 2022.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over BFLY on earnings quality, reporting a profit while its opponent remains loss making.
BFLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32.6M | +52% |
| Q2 2026 | $32.6M | +39% |
| Q1 2026 | $26.5M | +25% |
| Q4 2025 | $31.5M | +41% |
| Q3 2025 | $21.5M | +4.5% |
| Q2 2025 | $23.4M | +8.8% |
| Q1 2025 | $21.2M | +20% |
| Q4 2024 | $22.4M | +35% |
BFLY's revenue has grown year over year for 11 quarters in a row: $33M last quarter, up 52% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -42% | +122 points |
| Q2 2026 | -42% | +27 points |
| Q1 2026 | -52% | +35 points |
| Q4 2025 | -53% | +24 points |
| Q3 2025 | -164% | -80 points |
| Q2 2025 | -69% | +11 points |
| Q1 2025 | -87% | +41 points |
| Q4 2024 | -77% | +206 points |
BFLY's operating margin was −42% last quarter, up 122 points from the same quarter a year ago, near the top of its range since 2019.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over BFLY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over BFLY on profitability, with a higher operating margin.
BFLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.4M | +$492K |
| Q2 2026 | -$17.2M | -$9.2M |
| Q1 2026 | -$14.8M | -$2.8M |
| Q4 2025 | $7.9M | +$11.5M |
| Q3 2025 | -$3.9M | +$4.4M |
| Q2 2025 | -$8.1M | +$2.7M |
| Q1 2025 | -$12M | +$9.8M |
| Q4 2024 | -$3.5M | +$12.1M |
BFLY has burned cash in almost every quarter: −$28M over the past year, against −$28M the year before.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over BFLY on cash generation, producing positive trailing cash flow while its opponent burns cash.
BFLY Net Leverage
BFLY's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
BFLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.3 | Neutral |
| Stochastic | 11.0 | Oversold |
BFLY's weekly RSI is 48 (neutral) and its Stochastic is 11 (oversold).
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
BFLY PE vs Healthcare Sector
BFLY has no meaningful PE right now: it lost money over the past year.
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
BFLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.50 | 11% below |
| 20 week MA | $7.71 | 13% below |
| 50 week MA | $5.72 | 17% above |
| 100 week MA | $4.12 | 62% above |
| 200 week MA | $2.87 | 132% above |
BFLY has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 132% above its 200-week average.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over BFLY on trend strength, trading above more of its moving averages.
BFLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.1 | $21.1 | +108% |
| 2021 | $21.1 | $7.39 | -65% |
| 2022 | $7.39 | $2.36 | -68% |
| 2023 | $2.36 | $1.08 | -54% |
| 2024 | $1.08 | $3.46 | +220% |
| 2025 | $3.46 | $3.85 | +11% |
| 2026 YTD | $3.85 | $6.67 | +73% |
BFLY's yearly returns have swung widely, from +220% in 2024 to −68% in 2022. It's up 73% so far in 2026.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over BFLY on returns for 2026, with the stronger performance.